{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:22:59Z","timestamp":1791181379069,"version":"4.1.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"BITS-Pilani"},{"name":"University Grants Commission, India"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.ejphar.2014.09.041","type":"journal-article","created":{"date-parts":[[2014,10,4]],"date-time":"2014-10-04T01:48:23Z","timestamp":1412387303000},"page":"59-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Ondansetron, a 5HT3 receptor antagonist reverses depression and anxiety-like behavior in streptozotocin-induced diabetic mice: Possible implication of serotonergic system"],"prefix":"10.1016","volume":"744","author":[{"given":"Deepali","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeshwant","family":"Kurhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2014.09.041_bib1","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.neulet.2012.10.045","article-title":"Anxiety correlates to decreased blood and prefrontal cortex IGF-1 levels in streptozotocin induced diabetes","volume":"531","author":"Aksu","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2014.09.041_bib2","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.2337\/diacare.24.6.1069","article-title":"The prevalence of comorbid depression in adults with diabetes a meta-analysis","volume":"24","author":"Anderson","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2014.09.041_bib3","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/j.1460-9568.2006.04691.x","article-title":"Reduced hippocampal neurogenesis and number of hilar neurones in streptozotocin\u2010induced diabetic mice: reversion by antidepressant treatment","volume":"23","author":"Beauquis","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2014.09.041_bib4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0149-7634(94)00050-B","article-title":"Role of the serotonergic system in the forced swimming test","volume":"19","author":"Borsini","year":"1995","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2014.09.041_bib5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0014-2999(03)01274-3","article-title":"The mouse light\/dark box test","volume":"463","author":"Bourin","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.09.041_bib6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1472-8206.2007.00526.x","article-title":"Animal models of anxiety in mice","volume":"21","author":"Bourin","year":"2007","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.09.041_bib7","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0306-4522(98)00693-9","article-title":"Depletion in serotonin decreases neurogenesis in the dentate gyrus and the subventricular zone of adult rats","volume":"89","author":"Brezun","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2014.09.041_bib8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ecl.2013.10.001","article-title":"Interactions between diabetes and anxiety and depression: implications for treatment","volume":"43","author":"Bystritsky","year":"2014","journal-title":"Endocrinol. Metab. Clin."},{"key":"10.1016\/j.ejphar.2014.09.041_bib9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.npep.2004.04.004","article-title":"Hyperglycemia induced by acute central fluoxetine administration: role of the central CRH system and 5-HT3 receptors","volume":"38","author":"Carvalho","year":"2004","journal-title":"Neuropeptides"},{"key":"10.1016\/j.ejphar.2014.09.041_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/0471142301.ns0810as55","article-title":"Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice","volume":"55","author":"Castagne","year":"2011","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.ejphar.2014.09.041_bib11","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2337\/diab.35.4.481","article-title":"Alterations in physiologic functions and in brain monoamine content in streptozocin-diabetic rats","volume":"35","author":"Chu","year":"1986","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2014.09.041_bib12","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1001\/archinte.160.21.3278","article-title":"Depression and diabetes: impact of depressive symptoms on adherence, function, and costs","volume":"160","author":"Ciechanowski","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ejphar.2014.09.041_bib13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0091-3057(80)90067-2","article-title":"Preliminary report of a simple animal behavior for the anxiolytic effects of benzodiazepines","volume":"13","author":"Crawley","year":"1980","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2014.09.041_bib14","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.neubiorev.2005.03.008","article-title":"Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2014.09.041_bib15","first-page":"41","article-title":"Distribution of 5-HT receptors in the mammalian brain","volume":"6","author":"Cubero","year":"2011","journal-title":"Trends Cell Mol. Biol."},{"key":"10.1016\/j.ejphar.2014.09.041_bib16","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1476-5381.1970.tb10373.x","article-title":"Rapid method for the determination of 5\u2010hydroxytryptamine and 5\u2010hydroxyindoleacetic acid in small regions of rat brain","volume":"39","author":"Curzon","year":"1970","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.09.041_bib17","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00006842-200107000-00015","article-title":"Association of depression and diabetes complications: a meta-analysis","volume":"63","author":"de Groot","year":"2001","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.ejphar.2014.09.041_bib18","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.biopsych.2006.03.082","article-title":"Hippocampal neurogenesis: regulation by stress and antidepressants","volume":"59","author":"Dranovsky","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.09.041_bib19","doi-asserted-by":"crossref","first-page":"464","DOI":"10.2337\/diacare.25.3.464","article-title":"Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes","volume":"25","author":"Egede","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2014.09.041_bib20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jad.2005.12.047","article-title":"Evidence for a vagal pathophysiology for bulimia nervosa and the accompanying depressive symptoms","volume":"92","author":"Faris","year":"2006","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.ejphar.2014.09.041_bib21","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10048-003-0143-2","article-title":"Genetic animal models of anxiety","volume":"4","author":"Finn","year":"2003","journal-title":"Neurogenetics"},{"key":"10.1016\/j.ejphar.2014.09.041_bib22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00592-010-0219-z","article-title":"Comparative validity of the WHO-5 Well-Being Index and two-question instrument for screening depressive symptoms in patients with type 2 diabetes","volume":"50","author":"Furuya","year":"2013","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.ejphar.2014.09.041_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2337\/diacare.23.1.23","article-title":"Depressive symptoms and metabolic control in African-Americans with type 2 diabetes","volume":"23","author":"Gary","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2014.09.041_bib24","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1471-4159.1966.tb09873.x","article-title":"Regional studies of catecholamines in the rat brain\u2010I","volume":"13","author":"Glowinski","year":"1966","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2014.09.041_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/10401230109147127","article-title":"Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy","volume":"13","author":"Goodnick","year":"2001","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.09.041_bib26","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.diabet.2013.06.003","article-title":"The impact of anxiety and depression on patients within a large type 1 diabetes insulin pump population. An observational study","volume":"39","author":"Grant","year":"2013","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.ejphar.2014.09.041_bib27","first-page":"5","article-title":"Problems with currently available antidepressants","volume":"61","author":"Gumnick","year":"2000","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.09.041_bib28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.pbb.2014.05.024","article-title":"5HT3 receptor antagonist (ondansetron) reverses depressive behavior evoked by chronic unpredictable stress in mice: modulation of hypothalamic\u2013pituitary\u2013adrenocortical and brain serotonergic system","volume":"124","author":"Gupta","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2014.09.041_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11011-014-9540-5","article-title":"Insulin reverses anxiety-like behavior evoked by streptozotocin-induced diabetes in mice","volume":"29","author":"Gupta","year":"2014","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ejphar.2014.09.041_bib30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00213-006-0337-z","article-title":"5HT3 antagonism abolishes the emotion potentiated startle effect in humans","volume":"186","author":"Harmer","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2014.09.041_bib31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0278-5846(00)00151-2","article-title":"The mouse light\u2013dark paradigm: a review","volume":"25","author":"Hascoet","year":"2001","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.09.041_bib32","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.4088\/JCP.v64n0907","article-title":"Pilot trial of ondansetron in the treatment of 8 patients with obsessive\u2013compulsive disorder","volume":"64","author":"Hewlett","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.09.041_bib33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pbb.2006.12.003","article-title":"Antidepressant-like effect of leptin in streptozotocin-induced diabetic mice","volume":"86","author":"Hirano","year":"2007","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2014.09.041_bib34","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.neubiorev.2013.03.010","article-title":"Effects of diabetes on hippocampal neurogenesis: links to cognition and depression","volume":"37","author":"Ho","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2014.09.041_bib35","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.genhosppsych.2010.10.008","article-title":"Prevalence and incidence of anxiety disorders in diabetic patients: a national population-based cohort study","volume":"33","author":"Huang","year":"2011","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.09.041_bib36","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1097\/01.ALC.0000095635.46911.5D","article-title":"Ondansetron reduces mood disturbance among biologically predisposed, alcohol-dependent individuals","volume":"27","author":"Johnson","year":"2003","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.ejphar.2014.09.041_bib37","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0091-3057(03)00080-7","article-title":"Effects of selective serotonin reuptake inhibitors on immobility time in the tail suspension test in streptozotocin-induced diabetic mice","volume":"75","author":"Kamei","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2014.09.041_bib38","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000180298","article-title":"Role of 5-hydroxytryptamine in the regulation of brain neuropeptides in normal and diabetic rat","volume":"23","author":"Kolta","year":"1986","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.ejphar.2014.09.041_bib39","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4088\/JCP.v67n0313","article-title":"Effect of mirtazapine treatment on body composition and metabolism","volume":"67","author":"Laimer","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.09.041_bib40","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00125-007-0886-7","article-title":"The mechanisms of alloxan and streptozotocin induced diabetes","volume":"51","author":"Lenzen","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2014.09.041_bib41","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/FBP.0b013e328308f1d6","article-title":"Food restriction and streptozotocin treatment decrease 5-HT1A and 5-HT2A receptor mediated behavioral effects in rats","volume":"19","author":"Li","year":"2008","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.09.041_bib42","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1046\/j.1464-5491.2000.00260.x","article-title":"Prevalence of symptoms of depression and anxiety in a diabetes clinic population","volume":"17","author":"Lloyd","year":"2000","journal-title":"Diabet. Med."},{"key":"10.1016\/j.ejphar.2014.09.041_bib43","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2337\/diacare.11.8.605","article-title":"Depression in adults with diabetes. Results of 5-yr follow-up study","volume":"11","author":"Lustman","year":"1988","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2014.09.041_bib44","first-page":"113","article-title":"Depression in diabetic patients: the relationship between mood and glycemic control","volume":"19","author":"Lustman","year":"2005","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.ejphar.2014.09.041_bib45","doi-asserted-by":"crossref","first-page":"618","DOI":"10.2337\/diacare.23.5.618","article-title":"Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial","volume":"23","author":"Lustman","year":"2000","journal-title":"Diabetes care"},{"key":"10.1016\/j.ejphar.2014.09.041_bib46","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00006842-199705000-00007","article-title":"Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial","volume":"59","author":"Lustman","year":"1997","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.ejphar.2014.09.041_bib47","doi-asserted-by":"crossref","first-page":"9104","DOI":"10.1523\/JNEUROSCI.20-24-09104.2000","article-title":"Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus","volume":"20","author":"Malberg","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2014.09.041_bib48","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0014-2999(00)00904-3","article-title":"Antidepressants alter cell proliferation in the adult brain in vivo and in neural cultures in vitro","volume":"411","author":"Manev","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.09.041_bib49","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1080\/15622970902717032","article-title":"Functional change of the auditory cortex related to brain serotonergic neurotransmission in type 1 diabetic adolescents with and without depression","volume":"10","author":"Manjarrez-Gutierrez","year":"2009","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.09.041_bib50","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/S0149-2918(03)80220-5","article-title":"Tolerability and adherence issues in antidepressant therapy","volume":"25","author":"Masand","year":"2003","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ejphar.2014.09.041_bib51","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0306-4530(89)90064-4","article-title":"Helpless behavior (escape deficits) in streptozotocin-diabetic rats: resistance to antidepressant drugs","volume":"14","author":"Massol","year":"1989","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ejphar.2014.09.041_bib52","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/sj.npp.1300354","article-title":"Diabetes attenuates the antidepressant-like effect mediated by the activation of 5-HT1A receptor in the mouse tail suspension test","volume":"29","author":"Miyata","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2014.09.041_bib53","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.brainres.2007.02.001","article-title":"Diabetes attenuates psychological stress-elicited 5-HT secretion in the prefrontal cortex but not in the amygdala of mice","volume":"1147","author":"Miyata","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2014.09.041_bib54","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/01.jcp.0000095341.32154.8f","article-title":"African women with depression: the effect of imipramine and fluoxetine on body mass index and leptin secretion","volume":"23","author":"Moosa","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2014.09.041_bib55","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0006-3223(03)00569-9","article-title":"Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment","volume":"54","author":"Musselman","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.09.041_bib56","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/1099-1077(200008)15:6<397::AID-HUP212>3.0.CO;2-L","article-title":"A review of the role of serotonin receptors in psychiatric disorders","volume":"15","author":"Naughton","year":"2000","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2014.09.041_bib57","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/hup.496","article-title":"Animal models of depression: are there any","volume":"18","author":"O\u2019Neill","year":"2003","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2014.09.041_bib58","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/YCO.0b013e3283207b45","article-title":"Treatment of depression in diabetes: an update","volume":"22","author":"Petrak","year":"2009","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.09.041_bib59","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/gut.2004.055251","article-title":"Effect of ondansetron, a 5-HT3 receptor antagonist, on fatigue in chronic hepatitis C: a randomized, double blind, placebo controlled study","volume":"54","author":"Piche","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.ejphar.2014.09.041_bib60","first-page":"327","article-title":"Behavioural despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.ejphar.2014.09.041_bib61","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/FBP.0b013e3282f3cfd4","article-title":"Antidepressant-like effects of serotonin type-3 antagonist, ondansetron: an investigation in behavior-based rodent models","volume":"19","author":"Ramamoorthy","year":"2008","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.09.041_bib62","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s002130050523","article-title":"Differential effects of diazepam on anxiety in streptozotocin induced diabetic and non-diabetic rats","volume":"135","author":"Ramanathan","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2014.09.041_bib63","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.tips.2008.07.005","article-title":"Animal models of anxiety: do I need multiple tests","volume":"29","author":"Ramos","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2014.09.041_bib64","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0014-2999(97)00115-5","article-title":"Partial role of 5-HT2 and 5-HT3 receptors in the activity of antidepressants in the mouse forced swimming test","volume":"325","author":"Redrobe","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.09.041_bib65","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/1520-6394(2000)12:1+<2::AID-DA2>3.0.CO;2-4","article-title":"Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders","volume":"12","author":"Ressler","year":"2000","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.ejphar.2014.09.041_bib66","first-page":"43","article-title":"Antidepressant psychopharmacology: current limitations and future directions","volume":"10","author":"Robinson","year":"2003","journal-title":"Prim. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.09.041_bib67","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0091-3057(96)00402-9","article-title":"Risk assessment Hewlettior: evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test","volume":"57","author":"Rodgers","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2014.09.041_bib68","first-page":"107","article-title":"Anti-anxiety profile of ondansetron, a selective 5-HT3 antagonist, in a novel animal model","volume":"19","author":"Roychoudhury","year":"1997","journal-title":"Method Find. Exp. Clin."},{"key":"10.1016\/j.ejphar.2014.09.041_bib69","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0024-3205(97)00084-2","article-title":"Streptozotocin-induced diabetes provokes changes in serotonin concentration and on 5-HT1A and 5-HT2 receptors in the rat brain","volume":"60","author":"Sandrini","year":"1997","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2014.09.041_bib70","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.1083328","article-title":"Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants","volume":"301","author":"Santarelli","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2014.09.041_bib71","series-title":"Neurodegenerative Diseases","first-page":"349","article-title":"Hormonal signaling systems of the brain in diabetes mellitus","author":"Shpakov","year":"2011"},{"key":"10.1016\/j.ejphar.2014.09.041_bib72","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0014-2999(98)00223-4","article-title":"Changes in head-dipping behavior in the hole-board test reflect the anxiogenic and\/or anxiolytic state in mice","volume":"350","author":"Takeda","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.09.041_bib73","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00592-011-0275-z","article-title":"A cross-sectional survey of depression, anxiety, and cognitive function in patients with type 2 diabetes","volume":"49","author":"Trento","year":"2012","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.ejphar.2014.09.041_bib74","first-page":"128","article-title":"Diabetes mellitus decreases hippocampal release of neurotransmitters: an in vivo microdialysis study of awake, freely moving rats","volume":"17","author":"Yamato","year":"2004","journal-title":"Diabetes Nutr. Metab."},{"key":"10.1016\/j.ejphar.2014.09.041_bib75","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-0404.2007.00928.x","article-title":"Impairment of hippocampal neurogenesis in streptozotocin\u2010treated diabetic rats","volume":"117","author":"Zhang","year":"2008","journal-title":"Acta Neurol. Scand."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299914006979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299914006979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T10:58:32Z","timestamp":1598353112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299914006979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":75,"alternative-id":["S0014299914006979"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.09.041","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ondansetron, a 5HT3 receptor antagonist reverses depression and anxiety-like behavior in streptozotocin-induced diabetic mice: Possible implication of serotonergic system","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.09.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}